Monoclonal antibodies in gastrointestinal cancers.

Monoclonal antibodies in gastrointestinal cancers.

Item
http://www.wikidata.org/entity/Q38084684
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study.Vitamin k2, a naturally occurring menaquinone, exerts therapeutic effects on both hormone-dependent and hormone-independent prostate cancer cellsFrom conventional chemotherapy to targeted therapy: use of monoclonal antibodies (moAbs) in gastrointestinal (GI) tumors.Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario.Pharmacogenomics of cetuximab in metastatic colorectal carcinoma.Impact of the immune system and immunotherapy in colorectal cancer.Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma.
P2860

Monoclonal antibodies in gastrointestinal cancers.

Item
http://www.wikidata.org/entity/Q38084684
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Monoclonal antibodies in gastrointestinal cancers.
@en
type
label
Monoclonal antibodies in gastrointestinal cancers.
@en
prefLabel
Monoclonal antibodies in gastrointestinal cancers.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Monoclonal antibodies in gastrointestinal cancers
@en
P2093
P2860
P304
P31
P356
10.1517/14712598.2013.774367
P407
P433
P478
P50
P577
P5875
P698